RMS Korea on bumpy road

Published: 2008-12-11 06:59:00

Updated: 2008-12-11 06:59:00

RMS Korea plans to acquire financially distressed Inyoung Pharm at the end of this year to expand its presence in the domestic drug logistics market.

However, the company has been facing strong challenge from local wholesalers and pharmaceutical firms.

A group of wholesaling business offici...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK